Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Spectral CMO John Kellum

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 19, 2024 11:48pm

189 Views

Post# 35888210

RE:RE:Spectral CMO John Kellum

Small Correction ....

they had their "panties in a bunch" ... for no good reason ('cept maybe nefarious ones)....as per usual.

No way that JK walks away from a career defining moment like this.

Looking forward to the joint release by Baxter and Spectral coming soon.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale